216 related articles for article (PubMed ID: 218214)
41. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
[TBL] [Abstract][Full Text] [Related]
42. Receptors for vasoactive intestinal polypeptide on crude smooth muscle membranes from porcine uterus.
Ottesen B; Staun-Olsen P; Gammeltoft S; Fahrenkrug J
Endocrinology; 1982 Jun; 110(6):2037-43. PubMed ID: 6280985
[No Abstract] [Full Text] [Related]
43. Cholecystokinin downregulates receptors for vasoactive intestinal peptide and secretin in rat pancreatic acini.
Katsushima S; Adachi H; Honda T; Sato S; Kusui T; Onishi S; Aoki E; Noguchi M; Konishi J
Am J Physiol; 1990 Mar; 258(3 Pt 1):G395-403. PubMed ID: 2156442
[TBL] [Abstract][Full Text] [Related]
44. Characterization of vasoactive intestinal peptide receptors in rat seminal vesicle.
Guijarro LG; Rodriguez-Pena MS; Prieto JC
Am J Physiol; 1991 Feb; 260(2 Pt 1):E286-91. PubMed ID: 1847588
[TBL] [Abstract][Full Text] [Related]
45. Importance of the amino acid in position 15 of VIP and secretin in influencing their interactions with membrane receptors on pancreatic acinar cells.
Gardner JD; Rottman AJ; Fink ML; Natarajan S; Bodanszky M
Endocrinol Jpn; 1980 Dec; 27 Suppl 1():1-5. PubMed ID: 6262063
[TBL] [Abstract][Full Text] [Related]
46. Characteristics of receptors for VIP in rat peritoneal macrophage membranes.
Calvo JR; Guerrero JM; López-Gonzalez MA; Osuna C; Segura JJ
Peptides; 1994; 15(2):309-15. PubMed ID: 8008637
[TBL] [Abstract][Full Text] [Related]
47. Characterization and solubilization of vasoactive intestinal peptide receptors from rat lung membranes.
Provow S; Veliçelebi G
Endocrinology; 1987 Jun; 120(6):2442-52. PubMed ID: 3032591
[TBL] [Abstract][Full Text] [Related]
48. Vasoactive intestinal peptide (VIP): brain distribution, subcellular localization and effect of deafferentation of the hypothalamus in male rats.
Besson J; Rotsztejn W; Laburthe M; Epelbaum J; Beaudet A; Kordon C; Rosselin G
Brain Res; 1979 Apr; 165(1):79-85. PubMed ID: 427588
[No Abstract] [Full Text] [Related]
49. VIP regulation of a human pancreatic cancer cell line: Capan-1.
Ruellan C; Scemama JL; Clerc P; Fagot-Revurat P; Clemente F; Ribet A
Peptides; 1986; 7 Suppl 1():267-71. PubMed ID: 3018700
[TBL] [Abstract][Full Text] [Related]
50. Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages.
Sakakibara H; Shima K; Said SI
Am J Physiol; 1994 Sep; 267(3 Pt 1):L256-62. PubMed ID: 7943252
[TBL] [Abstract][Full Text] [Related]
51. Secretin receptors on neuroblastoma cell membranes: characterization of 125I-labeled secretin binding and association with adenylate cyclase.
Roth BL; Beinfeld MC; Howlett AC
J Neurochem; 1984 Apr; 42(4):1145-52. PubMed ID: 6321661
[TBL] [Abstract][Full Text] [Related]
52. Guanyl nucleotide regulation of vasoactive intestinal peptide interaction with rat liver membranes.
Ramírez-Cárdenas R; Prieto JC; Guerrero JM; Goberna R
Rev Esp Fisiol; 1981 Mar; 37(1):9-16. PubMed ID: 6264553
[TBL] [Abstract][Full Text] [Related]
53. Characterization of receptors for VIP on pancreatic acinar cell plasma membranes using covalent cross-linking.
McArthur KE; Wood CL; O'Dorisio MS; Zhou ZC; Gardner JD; Jensen RT
Am J Physiol; 1987 Mar; 252(3 Pt 1):G404-12. PubMed ID: 2435170
[TBL] [Abstract][Full Text] [Related]
54. Multiplicity of receptors for vasoactive intestinal polypeptide (VIP): differential effects of apamin on binding in brain, uterus and liver.
Fahrenkrug J; Gammeltoft S; Staun-Olsen P; Ottesen B; Sjöquist A
Peptides; 1983; 4(2):133-6. PubMed ID: 6312430
[TBL] [Abstract][Full Text] [Related]
55. PACAP and VIP receptors in rat liver membranes.
Robberecht P; Gourlet P; Cauvin A; Buscail L; De Neef P; Arimura A; Christophe J
Am J Physiol; 1991 Jan; 260(1 Pt 1):G97-102. PubMed ID: 1846275
[TBL] [Abstract][Full Text] [Related]
56. Receptors for vasoactive intestinal peptide in rat anterior pituitary glands: localization of binding to lactotropes.
Wanke IE; Rorstad OP
Endocrinology; 1990 Apr; 126(4):1981-8. PubMed ID: 2156675
[TBL] [Abstract][Full Text] [Related]
57. Receptors for vasoactive intestinal polypeptide on isolated synaptosomes from rat cerebral cortex. Heterogeneity of binding and desensitization of receptors.
Staun-Olsen P; Ottesen B; Bartels PD; Nielsen MH; Gammeltoft S; Fahrenkrug J
J Neurochem; 1982 Nov; 39(5):1242-51. PubMed ID: 6288868
[No Abstract] [Full Text] [Related]
58. Vasoactive intestinal peptide binding to specific receptors on rat parotid acinar cells induces amylase secretion accompanied by intracellular accumulation of cyclic adenosine 3'-5'-monophosphate.
Inoue Y; Kaku K; Kaneko T; Yanaihara N; Kanno T
Endocrinology; 1985 Feb; 116(2):686-92. PubMed ID: 2578385
[TBL] [Abstract][Full Text] [Related]
59. Functional receptors for vasoactive intestinal peptide on human osteosarcoma cells.
Hohmann EL; Tashjian AH
Endocrinology; 1984 Apr; 114(4):1321-7. PubMed ID: 6323142
[TBL] [Abstract][Full Text] [Related]
60. [Hormone and neuroeffector receptors in gastroenterology. A concrete example: the VIP (vasoactive intestinal peptide) receptors].
Christophe J; Waelbroeck M; Robberecht P
Acta Gastroenterol Belg; 1982; 45(7-8):280-91. PubMed ID: 6132511
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
